Defense-Side Litigation Funding: How It Actually Works

Why financing a defendant is structurally harder than financing a claimant, and the arrangements that have emerged to do it anyway.

Can a company being sued actually obtain litigation funding to defend itself? Not in the conventional non-recourse sense that plaintiff-side funding uses, because a successful defense produces no recovery to repay a funder from — but several distinct structures have emerged that let companies manage defense-side litigation risk and cost using external capital, each built around a different source of eventual repayment.

The most direct structure ties defense-side capital to a viable counterclaim the defendant is separately pursuing. Many defendants facing litigation also have their own affirmative claims arising from the same dispute, and a funder can finance that counterclaim on standard contingent terms — repaid from the counterclaim's recovery — effectively giving the company access to capital connected to the overall matter even though the funding is not, strictly speaking, financing the defense itself.

Portfolio-level defense programs address companies with a recurring volume of litigation exposure — insurers, large corporations facing product liability claims, or businesses in litigation-heavy industries — by financing a defined book of defense matters under a program structured around aggregate, predictable costs rather than any single case's outcome. These arrangements more closely resemble a financing or risk-transfer facility than a contingent litigation funding product, since there is no recovery-based repayment mechanism to build the economics around.

Fixed-fee and alternative fee arrangements with defense counsel, while not litigation funding in the traditional sense, serve a similar underlying business purpose: converting unpredictable hourly defense costs into a more budgetable, defined expense. Some litigation finance providers have begun structuring capital around these fee arrangements, effectively financing a law firm's or company's transition to alternative fee billing on defense matters, which shifts the underwriting question toward the credit profile of the paying party rather than the merits of the underlying dispute.

Because none of these structures replicate the clean, non-recourse logic of plaintiff-side funding, defense-side arrangements remain far less standardized and far less common across the litigation finance market as a whole, and companies exploring this space should expect a more bespoke, individually negotiated structure than the templated products available on the plaintiff side.

A company evaluating counterclaim-based defense financing typically starts by having counsel assess, separately from the defense itself, whether a viable affirmative claim actually exists arising from the same underlying dispute — a breach of the same contract, a related tort, or a claim the company had not previously prioritized pursuing because its focus was on defending the affirmative case against it. This assessment is functionally identical to how any plaintiff-side claim is evaluated for funding: liability, damages, and the counterparty's ability to pay. The distinguishing feature in the defense-side context is that the company may not have originally framed its own position as including an affirmative claim at all, making this threshold identification step, rather than the funding structure itself, the part of the process companies most often underestimate.

Portfolio-level defense programs require a different kind of preparation: the company or insurer typically needs to define the book of matters the program will cover with enough specificity — by claim type, jurisdiction, or business line — for a funder or risk-transfer counterparty to price the arrangement, and needs historical data on how similar matters within that defined book have resolved and cost to defend historically. Companies without this kind of aggregated defense-cost history across their litigation portfolio typically need to assemble it from outside counsel invoices and matter records before a program can be meaningfully priced, since the whole premise of a portfolio-level program is substituting aggregate, historical cost predictability for the unpredictability of any single matter's defense costs.

Fixed-fee and alternative fee financing arrangements shift the underwriting conversation toward the paying party's credit profile specifically because the capital provider's return in this structure does not depend on the underlying litigation's outcome at all — it depends on the company's or firm's ability to pay under the fee arrangement itself, the same analysis a lender applies to any receivables-based financing. Companies exploring this structure should expect the diligence conversation to focus on their own financial statements and payment history rather than on the merits of the litigation being defended, which is a meaningfully different diligence experience than plaintiff-side funding conversations typically involve.

Because defense-side structures remain more bespoke than the standardized plaintiff-side funding product, companies exploring this space should expect a longer, more consultative structuring process before terms are finalized, and should come to that conversation prepared to discuss which of the underlying structures — counterclaim financing, a portfolio program, or fee-arrangement-based capital — actually fits their specific situation, since the three structures address genuinely different needs and are not interchangeable applications of the same underlying product the way plaintiff-side case funding largely is across different case types.

Coordinating counterclaim financing with an ongoing defense requires attention to how information flows between the team handling the affirmative claim and the team handling the defense, particularly where the funder's non-interference obligations and reporting rights on the counterclaim need to be kept separate from anything touching defense strategy the funder has no relationship to. Companies pursuing this structure typically clarify at the outset which counsel, or which specific attorneys within a single firm, are handling the counterclaim for funding purposes, so that the funder's reporting relationship has a clear, bounded scope rather than blurring into the broader litigation the company is also defending.

Companies exploring defense-side capital for the first time are generally well served by having counsel map out, before approaching any funder or program provider, which of the three structures actually corresponds to the company's specific situation, since presenting a clear picture of the underlying need considerably shortens the initial conversation with any capital provider being evaluated, compared to an open-ended inquiry about defense-side funding in the abstract.

Criterica Capital evaluates defense-side opportunities primarily through viable counterclaim financing and portfolio-level defense programs, structured around the specific facts and economics of each situation. Companies exploring defense-side capital options can contact our institutional team for a confidential discussion of available structures.

Discuss your matter with our institutional team.